AAX Biotech in an equity financing transaction with Trio Impact Invest in Sweden
01 February 2026
01 February 2026
Total investments received (USD): 679k
Round value (USD): N/A
Round investors: Trio Impact Invest
Company: AAX Biotech
Industry: BiotechHealth services
Related deals
ToxoTech to raise capital in a round backed by Industrifonden in Sweden
Investments
03 January 2026
Molecular Attraction in a new equity deal backed by UpRoot Capital
Investments
02 January 2026
Iflai was funded by BioVentureHub in Sweden
Investments
02 October 2025
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain